Table 1.
Pre-COVID | Mar–Apr 2019 | During COVID | p Value‡ | ||
---|---|---|---|---|---|
n | 14,163 | 729 | 1844 | ||
Median patient age (IQR) | 79 (67−87) | 79 (68−87) | 74 (61−83) | <0.001 | |
Age group (years) | Under 66 | 3199 (22.6%) | 160 (21.9%) | 595 (32.3%) | <0.001 |
66−77 | 3207 (22.6%) | 180 (24.7%) | 497 (27.0%) | ||
78−84 | 2810 (19.8%) | 142 (19.5%) | 345 (18.7%) | ||
85−90 | 2809 (19.8%) | 142 (19.5%) | 272 (14.8%) | ||
Over 90 | 2138 (15.1%) | 105 (14.4%) | 135 (7.3%) | ||
Sex | Female | 7373 (52.1%) | 366 (50.2%) | 865 (46.9%) | 0.143 |
Male | 6790 (47.9%) | 363 (49.8%) | 979 (53.1%) | ||
Co-morbidities | Cancer | 3502 (24.7%) | 203 (27.8%) | 214 (13.1%) | <0.001 |
Renal disease | 2759 (19.5%) | 135 (18.5%) | 316 (17.1%) | 0.439 | |
Congestive Cardiac Failure | 2694 (19.0%) | 119 (16.3%) | 189 (10.3%) | <0.001 | |
Liver Failure | 362 (2.6 %) | 17 (2.3 %) | 15 (0.8 %) | 0.003 | |
Palliative Care | 3816 (26.9%) | 208 (28.5%) | 308 (16.7%) | <0.001 | |
Critical Care | 502 (3.5%) | 19 (2.6%) | 62 (3.4%) | 0.387 | |
SEWS†† Risk | SEWS 0 | 4847 (34.2%) | 255 (35.4%) | 549 (29.8%) | 0.012 |
Low SEWS | 7056 (49.8%) | 334 (45.8%) | 959 (52.0%) | ||
Medium SEWS | 1287 (9.1%) | 79 (10.8%) | 196 (10.6%) | ||
High SEWS | 625 (4.4%) | 53 (7.3%) | 103 (5.6%) | ||
Missing SEWS Information | 348 (2.5%) | 8 (1.1%) | 37 (2.0%) | ||
Median Length of Stay (IQR) (Days)† | 14 (6−27) | 14(6−28) | 6 (3−13) | <0.001 | |
Patient status at discharge† | Alive | 9627 (68.0%) | 505 (69.5%) | 1290 (77.3%) | <0.001 |
Deceased | 4531 (32.0%) | 222 (30.5%) | 378 (22.7%) |
This is only given for the patients who have been discharged when the study was completed.
SEWS — Standardised Early Warning Scoring system.
This P value compares the COVID period to those forms completed in March and April 2019.